LCM
GH icon

Logan Capital Management’s Guardant Health GH Stock Holding History

Logan Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-53
Closed -$4K – 537
2022
Q1 		$4K Hold
53
– – ﹤0.01% 482
2021
Q4 		$5K Sell
53
-49
-48% -$5.07K ﹤0.01% 492
2021
Q3 		$13K Hold
102
– – ﹤0.01% 446
2021
Q2 		$13K Hold
102
– – ﹤0.01% 443
2021
Q1 		$16K Buy
+102
New +$15.4K ﹤0.01% 411

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Logan Capital Management's GH Position: Q2 2022 in Review

Logan Capital Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 53 shares — an estimated $4K sold.

Logan Capital Management first reported a position in GH in Q1 2021 and held it in 5 quarters. The position peaked at $16K in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Logan Capital Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Logan Capital Management sold 53 Guardant Health shares in Q2 2022, an estimated $4K.
  • Logan Capital Management first reported a position in Guardant Health in Q1 2021 and held it in 5 quarters.
  • Logan Capital Management's Guardant Health position peaked at $16K in Q1 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Logan Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.